Stocks DUOL Financial statements
Financial statementsDuolingo, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Duolingo, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 162 | 251 | 369 | 531 | 748 | 1,038 |
| Cost of revenue | 46 | 69.2 | 99.4 | 142 | 204 | 288 |
| Gross profit | 116 | 182 | 270 | 389 | 544 | 749 |
| Research and development | 53 | 104 | 150 | 194 | 235 | 306 |
| Selling and marketing | 35 | 59.2 | 67 | 75.8 | 90.5 | 126 |
| General and administrative | 43.7 | 78.6 | 118 | 132 | 156 | 182 |
| Operating expenses | 132 | 242 | 335 | 402 | 482 | 614 |
| Operating income | -16 | -60 | -65.2 | -13.3 | 62.6 | 136 |
| Other non-operating income | 0.07 | 0.03 | -0.68 | -0.06 | -2.99 | 1.61 |
| Pre-tax income | -15.7 | -60 | -58.6 | 17.8 | 102 | 182 |
| Income tax | 0.07 | 0.18 | 0.94 | 1.71 | 13.7 | -232 |
| Net income | -15.8 | -60.1 | -59.6 | 16.1 | 88.6 | 414 |
| EBITDA | -13.8 | -57.3 | -60.3 | -6.16 | 73.4 | 150 |
| EPS, basic | -1.24 | -2.57 | -1.51 | 0.39 | 2.04 | 9.05 |
| EPS, diluted | -1.24 | -2.57 | -1.51 | 0.35 | 1.88 | 8.57 |
| Shares, basic (weighted) | 12.7 | 23.4 | 39.5 | |||
| Shares, diluted (weighted) | 12.7 | 23.4 | 39.5 | 46.5 | 47.1 | 48.3 |
Balance sheet
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 120 | 554 | 608 | 748 | 786 | 1,036 |
| Receivables | 20.5 | 33.2 | 46.7 | 89 | 129 | 163 |
| Other current assets | 3.86 | 7.97 | 7.23 | 7.28 | 14.8 | 16.6 |
| Total current assets | 158 | 619 | 697 | 898 | 1,102 | 1,437 |
| Property, plant and equipment | 6.43 | 8.21 | 13 | 11.8 | 18.9 | 36.3 |
| Lease right-of-use assets | 8.07 | 28.4 | 22.5 | 19.1 | 47.5 | 80.4 |
| Goodwill | 0 | 4.05 | 4.05 | 10.5 | 35.3 | |
| Intangible assets | 4.57 | 8.5 | 16 | 19.9 | 28.3 | |
| Long-term investments | 0 | 98.3 | 135 | |||
| Other non-current assets | 0.56 | 0.89 | 1.51 | 1.72 | 1.56 | 10.1 |
| Total assets | 176 | 661 | 747 | 954 | 1,302 | 1,992 |
| Accounts payable | 2.2 | 7.82 | 1.18 | 2.45 | 6.38 | 8 |
| Accrued liabilities | 8.63 | 12.9 | 22 | 24.9 | 36.4 | 45.7 |
| Deferred revenue | 54.8 | 98.3 | 158 | 249 | 373 | 496 |
| Total current liabilities | 65.7 | 119 | 182 | 277 | 422 | 551 |
| Lease liabilities | 8.13 | 29.1 | 23.5 | 21.1 | 54.7 | 93.8 |
| Other non-current liabilities | 0 | |||||
| Total liabilities | 73.8 | 148 | 205 | 298 | 477 | 645 |
| Paid-in capital | 30.1 | 684 | 773 | 870 | 950 | 1,059 |
| Retained earnings | -111 | -171 | -230 | -214 | -126 | 288 |
| Treasury stock | 0 | |||||
| Shareholders' equity | -80.7 | 513 | 542 | 656 | 825 | 1,347 |
| Total equity | -80.7 | 513 | 542 | 656 | 825 | 1,347 |
| Total liabilities and equity | 176 | 661 | 747 | 954 | 1,302 | 1,992 |
| Shares outstanding | 12.8 | 16.6 |
Cash flow statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -15.8 | -60.1 | -59.6 | 16.1 | 88.6 | 414 |
| Depreciation and amortization | 2.26 | 2.73 | 4.87 | 7.1 | 10.9 | 14.4 |
| Stock-based compensation | 17 | 40.8 | 73.8 | 95.2 | 110 | 137 |
| Deferred income tax | 0 | 0 | -0.22 | -0.13 | 0.16 | -227 |
| Change in receivables | -10.4 | -12.7 | -13.6 | -42.2 | -39.9 | -33.9 |
| Change in payables | -1.62 | 5.62 | -6.66 | 1.26 | 3.93 | 1.62 |
| Cash from operations | 17.7 | 9.17 | 53.7 | 154 | 286 | 388 |
| Capital expenditures | -3.38 | -3.59 | -5.56 | -3.19 | -12.1 | -18.1 |
| Acquisitions | 0 | 0 | -4.05 | 0 | -6.6 | -33.1 |
| Purchases of investments | 0 | 0 | -193 | -163 | ||
| Sales and maturities of investments | 0 | 0 | 3.71 | 116 | ||
| Cash from investing | -4.01 | -6.21 | -14.2 | -13.6 | -217 | -108 |
| Stock issued | 2.03 | 12.5 | 14.8 | 13.6 | 19.4 | 12.6 |
| Share buybacks | 0 | -0.87 | 0 | 0 | ||
| Cash from financing | 47 | 430 | 14.8 | 2.14 | -30 | -29.5 |
| Net change in cash | 60.6 | 433 | 54.3 | 142 | 38.2 | 251 |
| Free cash flow | 14.3 | 5.58 | 48.1 | 150 | 273 | 370 |
| Interest paid | 0 | 0 | 0 | 0 | ||
| Income taxes paid | 0 | 0.13 | 0.62 | 2.32 | 7.62 | 14.4 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 72.7% | Gross profit / revenue. |
| Operating margin | 13.7% | Operating income / revenue. |
| EBITDA margin | 14.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 17.6% | Pre-tax income / revenue. |
| Net margin | 35.9% | Net income / revenue. |
| FCF margin | 35.6% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 37.6% | Cash from operations / revenue. |
| Effective tax rate | -103.5% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 29.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 19.8% | Net income / average total assets. |
| Return on invested capital (ROIC) | 54.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 29.5% | Research and development expense / revenue. |
| Stock-based pay / revenue | 12.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.0% | Capital expenditures / revenue. |
| D&A / revenue | 0.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 38.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 41.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 45.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 37.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 40.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 45.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 116.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 104.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | 367.5% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | 355.9% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | 35.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 93.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 85.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 35.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 97.4% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 91.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 63.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 35.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 53.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 38.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 62.5% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 2.6% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 7.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 30.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.72x | Current assets / current liabilities. |
| Quick ratio | 2.27x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 2.04x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 32.0% | Total liabilities / total assets. |
| Working capital | $993.3M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 3.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $1.35B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.55x | Revenue / average total assets. |
| Fixed asset turnover | 26.9x | Revenue / average property, plant and equipment. |
| Receivables turnover | 8.74x | Revenue / average receivables. |
| Days sales outstanding | 42 days | 365 x average receivables / revenue. |
| Days payables | 19 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 99.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 5.3% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $8.21 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $22.89 | Revenue / diluted weighted shares. |
| FCF per share | $8.15 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $8.61 | Cash from operations / diluted weighted shares. |
| Book value per share | $28.18 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $26.92 | Tangible book value / shares outstanding. |
| Cash per share | $23.60 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $6.71B | Share price x shares outstanding. |
| Enterprise value | $5.53B | Market cap + total debt - cash - short-term investments. |
| P/E | 16.3x | Market cap / net income. Only when net income is positive. |
| P/S | 5.86x | Market cap / revenue. |
| P/B | 4.76x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 4.99x | Market cap / tangible book value, when positive. |
| P/FCF | 16.5x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 15.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 4.83x | Enterprise value / revenue. |
| EV/EBIT | 35.2x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 33.0x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 13.6x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 6.1% | Free cash flow / market cap. |
| Earnings yield | 6.1% | Net income / market cap (the inverse of P/E). |
What was Duolingo, Inc.'s revenue in fiscal 2025?
Duolingo, Inc. reported revenue of $1.04B for fiscal 2025, 38.7% higher than the year before.
Was Duolingo, Inc. profitable in fiscal 2025?
Yes. Net income was $414.1M, a net margin of 39.9%.
How much free cash flow did Duolingo, Inc. generate in fiscal 2025?
Cash from operations of $387.8M minus capital expenditures of $18.1M left free cash flow of $369.7M.